Fateme Nikbakht

Fateme Nikbakht

Auto-generated profile, based on publicly available information

Fateme Nikbakht

Department of Epidemiology, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Knee Surgery & Related Research
Verified
Journal Article
Open access
PDF file
AJAfsaneh Jahani
Afsaneh Jahani
MEMohammad Ali Ebrahimzadeh
Mohammad Ali Ebrahimzadeh
MDMohsen Dehghani
Mohsen Dehghani
MSMaedeh Sharafoddin
Maedeh Sharafoddin
AMAli Moradi
Ali Moradi
NJNafiseh Jirofti
Nafiseh Jirofti
Background: Meniscal injuries, involving damage to the critical fibrocartilaginous structure of the knee joint, often necessitate surgical intervention, including meniscal allograft transplantation or the use of commercial implants. Despite advances in implant based therapies, there is no consensus regarding the comparative efficacy of collagen meniscus implants (CMI) versus polyurethane-based (PU-based) scaffolds. This review aimed to systematically evaluate and compare the clinical outcomes associated with these two implant types for partial meniscal repair. Methods: A comprehensive systematic review was conducted to evaluate the clinical outcomes of meniscal implants by searching multiple databases including Medline/PubMed, Web of Science, Embase, Scopus, and Cochrane in the temporal range of 1999–2024. The review focused on pre–post studies and assessed various patient-reported outcome measures, including the visual analog scale (VAS), international Knee Documentation Committee (IKDC), Lysholm, knee injury and osteoarthritis outcome score (KOOS), as well as the Tegner activity score. These outcomes were evaluated across different follow-up periods [short-term (6 month to 2.5 years), mid-term (2.5–5 years) and long-term (10 years)] following meniscal implant implantation. A random-effects meta-analysis model was used to address heterogeneity, along with a sensitivity analysis to evaluate the robustness of pooled estimates. The National Institutes of Health (NIH) quality assessment tool was utilized to assess the methodological quality in the studies. Results: The meta-analysis identified 26 studies that met the inclusion criteria, and the overall quality of the included studies was mostly fair to good. The analysis showed that both CMI and PU-based scaffolds improved clinical outcomes in patients with partial meniscus injuries, with the implants evaluated across short-term, mid-term, and long-term follow-up periods. Specifically, the analysis found: the VAS scores significantly improved during the short-term follow-up by an average of −1.86 points for CMI and −1.98 points for PU-based scaffolds. Lysholm scores significantly improved at short-term follow-up, increasing by an average of 29.26 points for CMI and 24.98 points for PU-based scaffolds. For the Tegner score, CMI implants showed an average increase of 2.02 points in the short-term, while PU-based implants exhibited a negligible change of −0.05 points. Conclusions: Both CMI and PU-based scaffolds demonstrated improved clinical outcomes, but showed some differences in effectiveness over follow-up periods. PU-based scaffolds offer faster integration and short-term effectiveness, while CMI promotes gradual tissue regeneration and long-term stability. Although these differing characteristics support personalized meniscal repair strategies, the lack of comparative studies limits definitive clinical guidance. Level of evidence: Level III, IV.

1 November 2025 in Journal of Research and Health
Verified
Journal Article
Closed access
IMIman Mousaei
Iman Mousaei
AMAmin Moradi
Amin Moradi
ATAli Taghipour
Ali Taghipour
MSMaryam Salari
Maryam Salari
FNFateme Nikbakht
Fateme Nikbakht
EFEhsan Mosa farkhani
Ehsan Mosa farkhani

26 March 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FNFateme Nikbakht
Fateme Nikbakht
HMHamid Heidarian Miri
Hamid Heidarian Miri
EMEhsan Mosafarkhani
Ehsan Mosafarkhani
FSFatemeh Sharifjafari
Fatemeh Sharifjafari
ATAli Taghipour
Ali Taghipour
Background: COVID-19 has rapidly spread around the world, and the duration of protective immunity against the virus remains unknown. Evidence suggests that patients with a confirmed COVID-19 infection may experience reinfection. The aim of this study is to determine the relationship between COVID-19 reinfection and previous infection history in the population covered by Mashhad University of Medical Sciences. Methods: This population-based, historical cohort study included all individuals with health records at the health service centers of Mashhad University of Medical Sciences who underwent PCR testing during the study period (April 1, 2020, up to February 19, 2022). The data were analyzed by calculating the infection rate in both PCR-positive and negative individuals, and estimating the adjusted rate ratio using Poisson regression. Results: The results of this study in the entire population showed that the incidence rate in people with a history of primary COVID-19 infection was 13% higher than that in people who had no history of this disease. However, in the group that received the vaccine prior to the first PCR test, the incidence rate was lower among individuals with a positive first test result (IRR = 0.71) compared to those with a negative first test result. Conclusion: The study reveals that prior COVID-19 infection does not ensure immunity and may increase the risk of reinfection, particularly among men and younger individuals. Vaccination appears to complicate this dynamic, as those with multiple vaccine doses showed higher reinfection rates compared to those with fewer doses. These findings highlight the need for ongoing research and tailored public health strategies to address the complexities of COVID-19 immunity and reinfection.